Champions Oncology Exhibiting at the 2012 AACR Annual Meeting

Hackensack, NJ – March 13, 2012 Champions Oncology is pleased to announce that it will be presenting five posters on its Champions TumorGraft™ models and Translational and Personalized Oncology Solutions at the 2012 American Association of Cancer Research (AACR) Annual Meeting on March 31 – April 4 in Chicago, IL. Champions will also be exhibiting at the event at Booth #1037.

The posters can be viewed during the following times during the AACR Annual Meeting. For questions, reprints of the posters, or to arrange a meeting during the event, please contact us.

 

Poster #DateTimeTitle
13674/2/2012 8am-12pmCharacterization of spontaneous metastases in Champions TumorGraft™ models
52524/2/2012 8am-12pmUtilization of TumorGraft technology for personalized breast cancer treatment
42494/3/2012 1pm-5pmDevelopment of Champions TumorGraft™ models in rare cancer types for oncology drug development
37554/3/2012 8am-12pmAntitumor activity of CEP-32496, a novel orally active BRAFV600E inhibitor, in a panel of Champions TumorGraft models of melanoma and colorectal cancer with B-Raf V600E mutations
13294/4/2012 8am-12pmPersonalizing gastrointestinal cancer treatment by the utilization of TumorGraft technology